Avricore Health Inc.
AVCRF
$0.0372
$0.010237.78%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -63.74% | 1.98% | 23.27% | 87.21% | 79.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -63.74% | 1.98% | 23.27% | 87.21% | 79.26% |
| Cost of Revenue | -87.10% | -5.30% | 8.11% | 107.89% | 53.25% |
| Gross Profit | -32.90% | 14.32% | 63.32% | 58.67% | 130.81% |
| SG&A Expenses | 26.82% | 15.50% | 9.44% | -37.70% | -15.22% |
| Depreciation & Amortization | 60.00% | 75.00% | 0.00% | -16.67% | 150.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -50.19% | 1.64% | 8.68% | 20.99% | 21.57% |
| Operating Income | -135.53% | 7.61% | 43.06% | 128.77% | 218.23% |
| Income Before Tax | -143.12% | -1,262.10% | 38.21% | 118.67% | 188.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -143.12% | -1,262.10% | 38.21% | 118.67% | 188.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -143.12% | -1,262.10% | 38.21% | 118.67% | 188.28% |
| EBIT | -135.53% | 7.61% | 43.06% | 128.77% | 218.23% |
| EBITDA | -109.27% | -5.69% | 71.70% | 215.06% | 494.82% |
| EPS Basic | -138.46% | -1,350.00% | 38.10% | 119.05% | 192.86% |
| Normalized Basic EPS | -142.86% | 33.33% | 38.46% | 115.38% | 177.78% |
| EPS Diluted | -138.46% | -- | 38.10% | 119.05% | 192.86% |
| Normalized Diluted EPS | -142.86% | 33.33% | 38.46% | 115.38% | 177.78% |
| Average Basic Shares Outstanding | 1.55% | 1.58% | 0.76% | 0.24% | 0.45% |
| Average Diluted Shares Outstanding | 1.55% | 1.58% | 0.76% | 6.00% | 0.45% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |